Orthofix Medical (OFIX) Competitors $18.91 +0.23 (+1.23%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends OFIX vs. SIBN, XENT, ANIK, VAPO, IART, ATRC, ATEC, SRDX, ANGO, and ARAYShould you be buying Orthofix Medical stock or one of its competitors? The main competitors of Orthofix Medical include SI-BONE (SIBN), Intersect ENT (XENT), Anika Therapeutics (ANIK), Vapotherm (VAPO), Integra LifeSciences (IART), AtriCure (ATRC), Alphatec (ATEC), Surmodics (SRDX), AngioDynamics (ANGO), and Accuray (ARAY). These companies are all part of the "medical" sector. Orthofix Medical vs. SI-BONE Intersect ENT Anika Therapeutics Vapotherm Integra LifeSciences AtriCure Alphatec Surmodics AngioDynamics Accuray SI-BONE (NASDAQ:SIBN) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations, profitability and community ranking. Does the media refer more to SIBN or OFIX? In the previous week, SI-BONE had 18 more articles in the media than Orthofix Medical. MarketBeat recorded 19 mentions for SI-BONE and 1 mentions for Orthofix Medical. Orthofix Medical's average media sentiment score of 0.60 beat SI-BONE's score of 0.26 indicating that Orthofix Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SI-BONE 4 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Orthofix Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, SIBN or OFIX? SI-BONE has higher earnings, but lower revenue than Orthofix Medical. SI-BONE is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSI-BONE$157.04M3.35-$43.34M-$0.92-13.65Orthofix Medical$746.64M0.97-$151.40M-$3.13-6.04 Is SIBN or OFIX more profitable? Orthofix Medical has a net margin of -15.18% compared to SI-BONE's net margin of -23.82%. Orthofix Medical's return on equity of -21.25% beat SI-BONE's return on equity.Company Net Margins Return on Equity Return on Assets SI-BONE-23.82% -22.51% -16.53% Orthofix Medical -15.18%-21.25%-13.29% Do insiders & institutionals have more ownership in SIBN or OFIX? 98.1% of SI-BONE shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 3.9% of SI-BONE shares are owned by insiders. Comparatively, 2.6% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more volatility and risk, SIBN or OFIX? SI-BONE has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500. Does the MarketBeat Community believe in SIBN or OFIX? Orthofix Medical received 245 more outperform votes than SI-BONE when rated by MarketBeat users. However, 68.29% of users gave SI-BONE an outperform vote while only 61.92% of users gave Orthofix Medical an outperform vote. CompanyUnderperformOutperformSI-BONEOutperform Votes16868.29% Underperform Votes7831.71% Orthofix MedicalOutperform Votes41361.92% Underperform Votes25438.08% Do analysts recommend SIBN or OFIX? SI-BONE presently has a consensus target price of $23.00, suggesting a potential upside of 83.12%. Orthofix Medical has a consensus target price of $23.00, suggesting a potential upside of 21.63%. Given SI-BONE's stronger consensus rating and higher probable upside, research analysts plainly believe SI-BONE is more favorable than Orthofix Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SI-BONE 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Orthofix Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 SummarySI-BONE beats Orthofix Medical on 11 of the 18 factors compared between the two stocks. Ad Genesis Gold GroupTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov Get Orthofix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OFIX vs. The Competition Export to ExcelMetricOrthofix MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$722.55M$4.53B$5.38B$8.84BDividend YieldN/A36.79%5.13%4.09%P/E Ratio-6.0425.65102.4617.58Price / Sales0.9746.931,234.85158.43Price / CashN/A53.6240.4736.33Price / Book1.375.947.096.50Net Income-$151.40M$13.99M$119.65M$226.22M7 Day Performance4.59%3.27%2.06%3.76%1 Month Performance20.68%4.64%-2.46%4.63%1 Year Performance66.90%47.15%33.95%29.20% Orthofix Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OFIXOrthofix Medical1.3573 of 5 stars$18.91+1.2%$23.00+21.6%+66.9%$722.55M$746.64M-6.041,634SIBNSI-BONE4.2817 of 5 stars$12.31+1.3%$23.00+86.9%-29.9%$516.24M$138.89M-13.38350Analyst ForecastInsider TradeXENTIntersect ENTN/A$28.24flatN/A+0.0%$954.91M$106.75M-5.90433Analyst ForecastANIKAnika Therapeutics3.6195 of 5 stars$17.43+1.5%$24.50+40.5%-17.5%$255.40M$166.66M-2.58357VAPOVapothermN/A$2.17-0.5%N/A-17.2%$13.59M$68.67M0.00290High Trading VolumeIARTIntegra LifeSciences2.8749 of 5 stars$23.00+0.3%$24.00+4.3%-39.8%$1.77B$1.54B-255.533,946Positive NewsHigh Trading VolumeATRCAtriCure3.4256 of 5 stars$35.68-1.0%$43.11+20.8%-14.5%$1.74B$399.24M-43.411,200Positive NewsATECAlphatec4.6743 of 5 stars$10.20+2.7%$17.11+67.8%-14.6%$1.45B$482.26M-7.98700Analyst ForecastSRDXSurmodics4.2084 of 5 stars$39.19+0.1%$50.00+27.6%+15.1%$559.24M$126.08M-48.38376Analyst ForecastANGOAngioDynamics4.743 of 5 stars$6.95+3.1%$12.00+72.7%-0.3%$282.38M$303.91M-1.11748Positive NewsARAYAccuray4.7058 of 5 stars$1.89+2.7%$9.00+377.5%-29.8%$189.57M$446.55M-10.94987Analyst RevisionNews Coverage Related Companies and Tools Related Companies SI-BONE Competitors Intersect ENT Competitors Anika Therapeutics Competitors Vapotherm Competitors Integra LifeSciences Competitors AtriCure Competitors Alphatec Competitors Surmodics Competitors AngioDynamics Competitors Accuray Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OFIX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orthofix Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orthofix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.